Revive Therapeutics Ltd (RVVTF)
0.0132
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Revive Therapeutics Total Liabilities (Quarterly): 2.461M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.461M |
| December 31, 2023 | 2.522M |
| September 30, 2023 | 2.588M |
| June 30, 2023 | 2.716M |
| December 31, 2022 | 3.192M |
| September 30, 2022 | 2.724M |
| June 30, 2022 | 3.463M |
| March 31, 2022 | 2.670M |
| December 31, 2021 | 1.109M |
| September 30, 2021 | 3.035M |
| June 30, 2021 | 0.8062M |
| March 31, 2021 | 0.801M |
| December 31, 2020 | 0.6976M |
| September 30, 2020 | 0.5326M |
| June 30, 2020 | 0.6088M |
| March 31, 2020 | 0.9538M |
| December 31, 2019 | 0.5901M |
| September 30, 2019 | 0.6664M |
| June 30, 2019 | 0.2451M |
| March 31, 2019 | 0.1962M |
| December 31, 2018 | 0.2006M |
| September 30, 2018 | 0.2089M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.2258M |
| March 31, 2018 | 0.2415M |
| December 31, 2017 | 0.2333M |
| September 30, 2017 | 0.2897M |
| June 30, 2017 | 0.2372M |
| March 31, 2017 | 0.2078M |
| December 31, 2016 | 0.3023M |
| September 30, 2016 | 0.4639M |
| June 30, 2016 | 0.6326M |
| March 31, 2016 | 0.5012M |
| December 31, 2015 | 0.3197M |
| September 30, 2015 | 0.3357M |
| June 30, 2015 | 0.2453M |
| March 31, 2015 | 0.1477M |
| December 31, 2014 | 0.108M |
| September 30, 2014 | 0.1301M |
| June 30, 2014 | 0.0729M |
| March 31, 2014 | 0.0327M |
| December 31, 2013 | 0.1973M |
| September 30, 2013 | 0.0149M |
| June 30, 2013 | 0.0261M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2451M
Minimum
Jun 2019
3.463M
Maximum
Jun 2022
1.704M
Average
1.109M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.727M |
| Shareholders Equity (Quarterly) | 7.266M |